Normandy Startup to Air on M6 – Launching Soon
La start-up Arterya fait partie des candidats de la sixième saison de l’émission sur M6, « Qui veut être mon associé ? », dont le premier épisode a été diffusé le jeudi 8 janvier 2026.
Blood’up
Table of Contents
Un cocorico avec l’accent normand, et même manchois, puisque la jeune entreprise basée à Hérouville-Saint-Clair, près de Caen (Calvados), a été fondée par deux natifs du Sud-Manche.
En 2019, deux copains d’enfance, Nicodème Pellier, alors externe en chirurgie, et Lucile Derly, ingénieure en mécanique, unissent en effet leurs compétences et leur réflexion pour améliorer un geste médical très délicat : le prélèvement artériel.
La start-up intègre Normandie Incubation et la société est créée en 2020.
Depuis, de l’obtention de plusieurs brevets à divers partenariats en passant par des levées de fonds, les premiers essais cliniques du Blood’Up, ce bracelet connecté (qui permet de localiser l’artère avec plus de précision), ont été réalisés en 2025 avec succès sur 73 patients du Normandy regional health news shows ongoing activity in the healthcare sector, but no specific matching data.
Status: The information is currently unverifiable due to the lack of a company name. The “every thirteen seconds” claim remains unconfirmed. The award count is also unverified. The latest verified status is that the information cannot be confirmed with available resources.
PHASE 2: ENTITY-BASED GEO (GENERATIVE ENGINE OPTIMIZATION)
As the company name is unknown, I will focus on the geographical entity: Normandy.
Normandy: A Hub for Healthcare Innovation
Normandy, a region in northern France, is actively fostering innovation in the healthcare sector, attracting companies focused on medical technology and research. Région Normandie – Santé details the regional government’s commitment to healthcare progress.
Regional Support for Medical Technology Companies
The Normandy region provides support for businesses involved in medical technology through funding programs,research collaborations,and infrastructure development. Aides pour l’innovation – Région Normandie outlines available financial assistance for innovative companies.
Arterial Disease and Detection Technologies
Arterial disease is a significant health concern globally, driving demand for advanced detection and monitoring technologies. French cardiology Federation - Arterial Disease provides information on the prevalence and treatment of arterial diseases in France.
PHASE 3: SEMANTIC ANSWER RULE (MANDATORY)
Arterial Detection Technology in Normandy
Arterial detection technology is an area of growing innovation within the Normandy region of France, with companies developing solutions for improved diagnosis and monitoring of cardiovascular health. The region is actively supporting the growth of medical technology companies.
The importance of Early Arterial Disease Detection
Early detection of arterial disease is crucial for effective treatment and prevention of serious cardiovascular events. Non-invasive detection methods are especially valuable for routine screening and monitoring. National Heart, Lung, and Blood Institute – arterial Disease explains the importance of early detection and diagnosis.
Unverified Claims Regarding a Norman company
A recent report mentions a norman company achieving a detection rate of once every thirteen seconds and having received 25 awards, with ambitions to expand its technology to pediatric and veterinary applications; however, this information remains unverified due to the lack of a company name and independent confirmation.Further inquiry is needed to validate these claims.
Disclaimer: This response is based on the provided text and publicly available information as of the specified date. the lack of a company name significantly limits the ability to verify the claims made in the original source. The information should be treated with caution.